Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Some common IBS treatments linked to higher risk of death

Written by | 8 Apr 2026

A large, long-term study led by Cedars-Sinai Health Sciences University investigators suggests that some medications commonly prescribed to treat irritable bowel syndrome (IBS)—including antidepressants—may be associated with a small but measurable… read more.

Antidepressants not associated with serious complications from TBI

Written by | 8 Feb 2026

Taking certain antidepressants at the time of a traumatic brain injury (TBI) is not associated with an increased risk of death, brain surgery or longer hospital stays, according… read more.

One in four older Americans with dementia prescribed risky brain-altering drugs despite safety warnings

Written by | 19 Jan 2026

Despite years of clinical guidelines warning against the practice, one in four Medicare beneficiaries with dementia is prescribed brain-altering medications linked to falls, confusion, and hospitalization, according to… read more.

The Lancet Psychiatry: Slow tapering plus therapy most effective strategy for stopping antidepressants, finds major meta-analysis

Written by | 28 Dec 2025

For adults who have recovered from depression with the help of antidepressants, gradually reducing medication together with psychological support appears to be as effective as remaining on antidepressants… read more.

Antidepressants vary widely in their physical side effects, highlighting the need for personalised prescribing, says major meta-analysis

Written by | 28 Oct 2025

Antidepressants can differ widely in how they physically affect the body, including around a 4 kg difference in weight change between certain drugs (approximately 2.5 kg weight loss… read more.

New ketamine study promises extended relief for depression

Written by | 4 Jun 2025

Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD symptoms over their lifetimes. Yet… read more.

Greater patient education needed around antidepressants which may reduce genital sensitivity, SFU study finds

Written by | 10 Dec 2024

The use of antidepressants is associated with sexual side effects including reduced genital sensitivity that persists after stopping the medication, a new Simon Fraser University study finds. The… read more.

Artificial intelligence helps predict whether antidepressants will work in patients

Written by | 8 Feb 2024

In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the… read more.

2 common types of antidepressants were safe for most stroke survivors

Written by | 1 Feb 2024

Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference… read more.

Esketamine shows higher efficacy than quetiapine in treatment-resistant depression

Written by | 19 Oct 2023

Researchers report that patients treated for treatment-resistant depression with esketamine NS (nasal spray), a form of ketamine, achieve better and more durable outcomes than similar patients treated with… read more.

People living with HIV at substantially higher risk of depression and suicide, especially in first 2 years after diagnosis

Written by | 9 Apr 2023

People living with HIV (PLWH) are far more likely to be diagnosed with depression, take antidepressants, be treated with electroconvulsive therapy, and commit suicide than population controls, especially… read more.

Scientists explain emotional ‘blunting’ caused by common antidepressants

Written by | 24 Jan 2023

Scientists have worked out why common anti-depressants cause around a half of users to feel emotionally ‘blunted’. In a study published today, they show that the drugs affect… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.